Purdue Institute for Drug Discovery

FA-TLR7a

Overview: 

Folate targeted TLR7 agonist for the treatment of autoimmune disorders and inflammatory diseases.

Status: 

Purdue Faculty: 

Dr. Philip Low

Development Partner: 

Eradivir